Cerba Lancet Africa Group

Cerba Lancet Africa is the leading network of clinical pathology and biomedical laboratories in Africa, with the ambition to become the leading diagnostic services provider in Africa and world-class standards of pathology services to patients and medical communities across the continent. Cerba Lancet Africa is a joint venture created in 2019 with the French group Cerba HealthCare, a leading international player in medical diagnosis, and Lancet Laboratories, the foremost name in clinical pathology in sub-Saharan Africa.

Through the Joint Venture, Cerba Lancet Africa operates a network of more than 100 ISO-accredited laboratories across 14 African countries: Botswana, Eswatini, Ethiopia, Gabon, Ghana, Ivory Coast, Kenya, Mozambique, Nigeria, Rwanda, Tanzania, Uganda, Zambia and Zimbabwe.

“Our goal is to provide Africa with the best medical diagnostic solutions at world-class standards to improve the quality of life of communities.”

Read more

4000
Tests in the Catalogue
170
Number of Sites
386900
Average Monthly Number of Tests
148100
Average Monthly Number of Patients

Our Mission

To be the leading force in local medical diagnostics in Africa, while offering the highest standards of pathology and biomedical services to patients and medical communities across the continent.

Our Vision

To provide Africa with the best medical diagnostic solutions at world-class standards to improve the quality of life of communities.

Our Values

Respect
Excellence
Commitment
Equity in Health

Latest News

All About HIV
Newsletters | 2022-12-02

HIV Integrase Inhibitors

Newsletters | 2022-12-02

Clinicians now have five classes of antiretroviral agents (ARVs) for the treatment of HIV infection in both treatment-naïve and treatment - experienced individuals.

Diabetes

Newsletters | 2022-11-02

Diabetes is a lifelong disease in which the body cannot process sugar properly. Diabetes is also called "diabetes mellitus" or "sugar diabetes". When people who have diabetes eat glucose, which is found in foods such as breads, potatoes and sweets, it can't be converted into energy. Instead of being converted into energy, the glucose stays in the blood.

Our Network

Ethiopia

  • No. labs: N .C.
  • * No. of patients: 24 200
  • * No. of tests performed: 39 900
* Average monthly number of

Gabon

  • No. labs: N .C.
  • * No. of patients: 2 800
  • * No. of tests performed: 14 500
* Average monthly number of

Ghana

  • No. labs: 27
  • * No. of patients: 39 000
  • * No. of tests performed: 148 500
* Average monthly number of

Kenya

  • No. labs: 34
  • * No. of patients: 32 000
  • * No. of tests performed: 103 000
* Average monthly number of

Nigeria

  • No. labs: 11
  • * No. of patients: 1 800
  • * No. of tests performed: 53 000
* Average monthly number of

Mozambique

  • No. labs: 2
  • * No. of patients: 1 300
  • * No. of tests performed: 5 400
* Average monthly number of

Rwanda

  • No. labs: 5
  • * No. of patients: 2 000
  • * No. of tests performed: 8 000
* Average monthly number of

Eswatini

  • No. labs: 5
  • * No. of patients: 6 200
  • * No. of tests performed: 17 300
* Average monthly number of

Tanzania

  • No. labs: 10
  • * No. of patients: 14 000
  • * No. of tests performed: 75 000
* Average monthly number of

Uganda

  • No. labs: 21
  • * No. of patients: 19 000
  • * No. of tests performed: 77 000
* Average monthly number of

Zambia

  • No. labs: 4
  • * No. of patients: 4 000
  • * No. of tests performed: 12 500
* Average monthly number of

Zimbabwe

  • No. labs: 23
  • * No. of patients: 24 000
  • * No. of tests performed: 78 000
* Average monthly number of

Current Network

  • Botswana
  • Ethiopia
  • Gabon
  • Ghana
  • Ivory Coast
  • Kenya
  • Nigeria
  • Mozambique
  • Rwanda
  • Eswatini
  • Tanzania
  • Uganda
  • Zambia
  • Zimbabwe

Cerba Lancet Africa on the continent

Botswana Eswatini Ethiopia Gabon Ghana Ivory Coast Kenya Mozambique Nigeria Rwanda Tanzania Uganda Zambia Zimbabwe